Delivery Order SPE2DB24D2100-SPE2DB24FBDTP
Award Date
9/27/24
Potential Completion Date
9/30/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA). The $57,987.46 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 3, 2023, with an ultimate completion date of April 4, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,168.13 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 11, 2024, with a completion date of December 12, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen, 3 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,498.14 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 24, 2024, with a completion date of September 25, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA), a defense agency. The $7,177.37 firm fixed price contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor, on June 27, 2024, with a completion date of June 28, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity to the Defense Logistics Agency (DLA). The $1,871.54 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 30, 2023. The contract has an ultimate completion date of March 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $3,483.24, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 5, 2024 with a completion date of September 6, 2024. The contract is a delivery order with a firm fixed price pricing type. There is no set-aside designation mentioned. AmerisourceBergen holds significant Indefinite Delivery...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $19,526.44 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024. This award is a child of a broader $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 ml) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $33,821.56 and a completion date of June 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The contract, valued at $3,531.84, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on November 6, 2024. The contract has a completion date of November 7, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Ozempic (0.25-0.5 mg/dose pen 3 mL) to the Defense Logistics Agency (DLA), a major defense agency. The $10,839.51 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. The contract is not set aside for any specific business type. As a key supplier of medical commodities to federal agencies, Amerisourcebergen holds several large...